Anxiety disorders and onset of cardiovascular disease: The differential impact of panic, phobias and worry

Journal of Anxiety Disorders

Volumn 28, Issue 2, 2014, Pages 252-258

  Batelaan, Neeltje M ^a   ten Have, Margreet ^b   van Balkom, Anton J L M ^a   Tuithof, Marlous ^b   de Graaf, Ron ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

Anxiety disorders; Cardiovascular disease; Cohort study; Population study; Risk factor

Indexed keywords

ADULT; AGORAPHOBIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PATIENT WORRY; PHOBIA; PSYCHOLOGIC ASSESSMENT; RELIABILITY; RISK FACTOR; SELF REPORT; SOCIAL PHOBIA; SOMATOFORM DISORDER; ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; EPIDEMIOLOGY; HEALTH SURVEY; MIDDLE AGED; NETHERLANDS; PANIC DISORDER; PHOBIC DISORDERS; PSYCHOLOGIC TEST; PSYCHOLOGY; RISK ASSESSMENT;

ADULT; ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; NETHERLANDS; PANIC DISORDER; PHOBIC DISORDERS; RISK ASSESSMENT;

EID: 84896706376     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2013.12.003     Document Type: Article

References (66)

1. Ahlbom A., Alfredsson L. Interaction: a word with two meanings creates confusion. European Journal of Epidemiology 2005, 20:563-564.
2. Albert C.M., Chae C.U., Rexrode K.M., Manson J.E., Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005, 111:480-487.
3. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., et al. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica. Supplementum 2004, 420:8-20.
4. American Psychiatric Association Diagnostic and Statistical Manuel of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
5. Baker M.M., Stabile M., Deri C. What do self-reported, objective measures of health measure? 2001, National Bureau of Economic Research, Cambridge.
6. Batelaan N., Smit F., de Graaf R., van Balkom A., Vollebergh W., Beekman A., et al. Economic costs of full-blown and subthreshold panic disorder. Journal of Affective Disorders 2007, 104:127-136.
7. Batelaan N.M., de Graaf R., Penninx B.W., van Balkom A.J., Vollebergh W.A., Beekman A.T. The 2-year prognosis of panic episodes in the general population. Psychological Medicine 2010, 40:147-157.
8. Batelaan N., Rhebergen D., de Graaf R., Spijker J., Beekman A.T., Penninx B.W. Panic attacks as a dimension of psychopathology: evidence for their impact on onset and course of mental disorders and functioning. Journal of Clinical Psychiatry 2012, 73:1195-1202.
9. Chen Y.H., Tsai S.Y., Lee H.C., Lin H.C. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosomatic Medicine 2009, 71:798-804.
10. Cohen H.W., Gibson G., Alderman M.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. American Journal of Medicine 2000, 108:2-8.
11. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 2003, 35:1381-1395.
12. de Graaf R., Ormel J., ten Have M., Burger H., Buist-Bouwman M.A. Mental disorders and service use in the Netherlands. Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders 2008, 388-405. Cambridge University Press, Cambridge. R.C. Kessler, T.B. Üstün (Eds.).
13. de Graaf R., ten Have M., van Dorsselaer S. The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods. International Journal of Methods in Psychiatric Research 2010, 19:125-141.
14. de Graaf R., ten Have M., van Gool C., van Dorsselaer S. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Social Psychiatry and Psychiatric Epidemiology 2012, 47:203-213.
15. Everson-Rose S.A., Lewis T.T. Psychosocial factors and cardiovascular diseases. Annual Review of Public Health 2005, 26:469-500.
16. Franco O.H., Peeters A., Bonneux L., de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005, 46:280-286.
17. Friedman B.H. An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biological Psychology 2007, 74:185-199.
18. Geiser F., Meier C., Wegener I., Imbierowiczm Conrad R., Liedtke R., Oldenburg J., Harbrecht U. Association between anxiety and factors of coagulation and fibrinolysis. Psychotherapy and Psychosomatics 2008, 77:377-383.
19. Gomez-Caminero A., Blumentals W.A., Russo L.J., Brown R.R., Castilla-Puentes R. Does panic disorder increase the risk of coronary heart disease. A cohort study of a national managed care database. Psychosomatic Medicine 2005, 67:688-691.
20. Haines A.P., Imeson J.D., Meade T.W. Phobic anxiety and ischaemic heart disease. British Medical Journal (Clinical Research Ed.) 1987, 295:297-299.
21. Hamer M., David B.G., Seldenrijk A., Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. European Heart Journal 2011, 32:437-442.
22. Haro J.M., Arbabzadeh-Bouchez S., Brugha T.S., de Girolamo G., Guyer M.E., Jin R., et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. International Journal of Methods in Psychiatric Research 2006, 15:167-180.
23. Hofmeijer-Sevink M.K., Batelaan N.M., van Megen H.J., Penninx B.W., Cath D.C., van den Hout M.A., et al. Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders 2012, 137:106-112.
24. Honkola J., Hookana E., Malinen S., Kaikkonen K.S., Junttila M.J., Isohanni M., et al. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. European Heart Journal 2012, 33:745-751.
25. Janszky I., Ahnve S., Lundberg I., Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. Journal of the American College of Cardiology 2010, 56:31-37.
26. Kawachi I., Colditz G.A., Ascherio A., Rimm E.B., Giovannucci E., Stampfer M.J., et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994, 89:1992-1997.
27. Kessler R.C., Keller M.B., Wittchen H.U. The epidemiology of generalized anxiety disorder. Psychiatric Clinics of North America 2001, 24:19-39.
28. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:617-627.
29. Kessler R.C., Chiu W.T., Jin R., Ruscio A.M., Shear K., Walters E.E. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry 2006, 63:415-424.
30. Knight M., Stewart-Brown S., Fletcher L. Estimating health needs: the impact of a checklist of conditions and quality of life measurement on health information derived from community surveys. Journal of Public Health Medicine 2001, 23:179-186.
31. Kubzansky L.D., Kawachi I., Spiro A., Weiss S.T., Vokonas P.S., Sparrow D. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997, 95:818-824.
32. Laan W., Termorshuizen F., Smeets H.M., Boks M.P., de Wit N.J., Geerlings M.I. A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder. Journal of Affective Disorders 2011, 135:284-291.
33. Marciniak M., Lage M.J., Landbloom R.P., Dunayevich E., Bowman L. Medical and productivity costs of anxiety disorders: case-control study. Depression and Anxiety 2004, 19(2):112-120.
34. Martens E.J., de Jonge P., Na B., Cohen B.E., Lett H., Whooley M.A. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease. The Heart and Soul Study. Archives of General Psychiatry 2010, 67:750-758.
35. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006, 3:e442.
36. National Center for Health Statistics Vital and health statistics. Evaluation of national health interview survey diagnostic reporting. Series 2: data evaluation and methods research, no. 120 1994, Department of Health and Human Services, Hyattsville, MD.
37. Nicholson A., Kuper H., Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. European Heart Journal 2006, 27:2763-2774.
38. National Institute for Health and Clinical Excellence Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care 2011, (Clinical guideline 113).
39. Papakostas G.I., Ongür D., Iosifescu D.V., Mischoulon D., Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. European Neuropsychopharmacology 2004, 14(March (2)):135-142.
40. Parker G., Hyett M., Hadzi-Pavlovic D., Brotchie H., Walsh W. GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome. Psychiatry Research 2011, 188:383-389.
41. Pate R.R., Pratt M., Blair S.N., Haskell W.L., Macera C.A., Bouchard C., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. Journal of American Medical Association 1995, 273:402-407.
42. Penninx B.W.J.H., Beekman A.T.F., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. International Journal of Methods in Psychiatric Research 2008, 17:121-140.
43. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). European Heart Journal 2012, 33:1635-1701.
44. Phillips A.C., Batty G.D., Gale C.R., Deary I.J., Osborn D., MacIntyre K. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam experience study. Psychosomatic Medicine 2009, 71:395-403.
45. Pitsavos C., Panagiotakos D.B., Papageorgiou C., Tsetsekou E., Soldatos C., Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA Study. Atherosclerosis 2006, 185:320-326.
46. Player M.S., Peterson L.E. Anxiety disorders, hypertension and cardiovascular risk: a review. International Journal of Psychiatry in Medicine 2011, 41(4):356-377.
47. Pratt L.A., Ford D.E., Crum R.M., Armenian H.K., Gallo J.J., Eaton W.W., et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996, 94:3123-3129.
48. Robins L.N., Wing J., Wittchen H.U., Helzer J.E., Babor T.F., Burke J., et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry 1988, 45:1069-1077.
49. Roest A.M., Martens E.J., de Jonge P., Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. Journal of the American College of Cardiology 2010, 56:38-46.
50. Roest A.M., Martens E.J., Denollet J., de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosomatic Medicine 2010, 72:563-569.
51. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
52. Seshasai S.R., Kaptoge S., Thompson A., Di Angelantonio E., Gao P., Sarwar N., et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine 2011, 364:829-841.
53. Shen B.J., Avivi Y.E., Todaro J.F., Spiro A., Laurenceau J.P., Ward K.D., et al. Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors. Journal of the American College of Cardiology 2008, 51:113-119.
54. Smoller J.W., Pollack M.H., Wassertheil-Smoller S., Jackson R.D., Oberman A., Wong N.D., et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Archives of General Psychiatry 2007, 64:1153-1160.
55. Smoller J.W., Allison M., Cochrane B.B., Curb J.D., Perlis R.H., Robinson J.G., et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Archives of Internal Medicine 2009, 169:2128-2139.
56. Stata Statistical Software. Release 11 [computer program] 2009, Statacorp LP, College Station, TX.
57. ten Have M., Nuyen J., Beekman A., de Graaf R. Common mental disorder severity and its association with treatment contact and treatment intensity for mental health problems. Psychological Medicine 2013, 43:2203-2213.
58. Thurston R.C., Kubzansky L.D., Kawachi I., Berkman L.F. Do depression and anxiety mediate the link between educational attainment and CHD. Psychosomatic Medicine 2006, 68:25-32.
59. Tyrer P., Baldwin D. Generalised anxiety disorder. Lancet 2006, 368:2156-2166.
60. US Department of Health and Human Services A report of the surgeon general: how tobacco smoke causes disease. The biology and behavioral basis for smoking-attributable disease 2010, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
61. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology 2006, 165:710-718.
62. Walters K., Rait G., Petersen I., Williams R., Nazareth I. Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. European Heart Journal 2008, 29:2981-2988.
63. Wang P.S., Lane M., Olfson M., Pincus H.A., Wells K.B., Kessler R.C. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:629-640.
64. World Health Organization Global atlas on cardiovascular disease prevention and control 2011, World Health Organization, Geneva.
65. Wittchen H.U. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. Journal of Psychiatric Research 1994, 28:57-84.
66. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.